155 related articles for article (PubMed ID: 37211774)
21. Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
Koshiol J; Yu B; Kabadi SM; Baria K; Shroff RT
BMC Cancer; 2022 Nov; 22(1):1178. PubMed ID: 36384474
[TBL] [Abstract][Full Text] [Related]
22. Advances in Targeted Immunotherapy for Hepatobiliary Cancers.
Ruff SM; Shannon AH; Pawlik TM
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430440
[TBL] [Abstract][Full Text] [Related]
23. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
Schweitzer N; Vogel A
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study.
Rizzato M; Brignola S; Munari G; Gatti M; Dadduzio V; Borga C; Bergamo F; Pellino A; Angerilli V; Mescoli C; Guido M; Rearden J; Gringeri E; Cillo U; Dei Tos AP; Zagonel V; Loupakis F; Lonardi S; Fassan M
Eur J Cancer; 2022 May; 166():165-175. PubMed ID: 35303508
[TBL] [Abstract][Full Text] [Related]
25. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.
Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K
Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103
[TBL] [Abstract][Full Text] [Related]
26. Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma.
Ishige K; Shoda J; Kawamoto T; Matsuda S; Ueda T; Hyodo I; Ohkohchi N; Puri RK; Kawakami K
Int J Cancer; 2008 Dec; 123(12):2915-22. PubMed ID: 18798553
[TBL] [Abstract][Full Text] [Related]
27. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Benson AB; D'Angelica MI; Abrams T; Abbott DE; Ahmed A; Anaya DA; Anders R; Are C; Bachini M; Binder D; Borad M; Bowlus C; Brown D; Burgoyne A; Castellanos J; Chahal P; Cloyd J; Covey AM; Glazer ES; Hawkins WG; Iyer R; Jacob R; Jennings L; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Ronnekleiv-Kelly S; Sahai V; Singh G; Stein S; Turk A; Vauthey JN; Venook AP; Yopp A; McMillian N; Schonfeld R; Hochstetler C
J Natl Compr Canc Netw; 2023 Jul; 21(7):694-704. PubMed ID: 37433432
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
29. Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.
Li YC; Li KS; Liu ZL; Tang YC; Hu XQ; Li XY; Shi AD; Zhao LM; Shu LZ; Lian S; Yan ZD; Huang SH; Sheng GL; Song Y; Liu YJ; Huan F; Zhang MH; Zhang ZL
Front Immunol; 2022; 13():1049812. PubMed ID: 36389727
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Chae H; Kim D; Yoo C; Kim KP; Jeong JH; Chang HM; Lee SS; Park DH; Song TJ; Hwang S; Kim KH; Song GW; Ahn CS; Lee JH; Hwang DW; Kim SC; Jang SJ; Hong SM; Kim TW; Ryoo BY
Eur J Cancer; 2019 Oct; 120():31-39. PubMed ID: 31476489
[TBL] [Abstract][Full Text] [Related]
31. Cholangioblastic variant of intrahepatic cholangiocarcinoma: A recently described biliary cancer in young patients.
Marichez A; Lavoine E; Bardou D; Marichez F
Dig Liver Dis; 2023 Aug; 55(8):1145-1146. PubMed ID: 37217374
[No Abstract] [Full Text] [Related]
32. Will advanced cholangiocarcinoma become a targetable malignancy?
Sarkis Y; Al Soueidy A; Kourie HR
Crit Rev Oncol Hematol; 2021 Mar; 159():103233. PubMed ID: 33482346
[TBL] [Abstract][Full Text] [Related]
33. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Vogel A; Bridgewater J; Edeline J; Kelley RK; Klümpen HJ; Malka D; Primrose JN; Rimassa L; Stenzinger A; Valle JW; Ducreux M;
Ann Oncol; 2023 Feb; 34(2):127-140. PubMed ID: 36372281
[No Abstract] [Full Text] [Related]
34. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
36. The evolution of biliary tract cancer: introducing a special focus issue from
Coyle L; Rizzo A; Ricci D
Immunotherapy; 2023 May; 15(7):471-472. PubMed ID: 37020402
[No Abstract] [Full Text] [Related]
37. [Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners].
Voesch S; Bitzer M; Malek N
Radiologe; 2022 Mar; 62(3):200-204. PubMed ID: 35147708
[TBL] [Abstract][Full Text] [Related]
38. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
Song S; Yang W; Tian H; Gong S; Lei C; Lv K; Lu T; Cheng Q; Yang K; Guo T
Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101788. PubMed ID: 34389530
[TBL] [Abstract][Full Text] [Related]
40. Unity is strength.
Maunoury V; Mordon S; Bulois P
Chemotherapy; 2011; 57(2):145-6. PubMed ID: 21454971
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]